Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Vaccine trial's ethics criticized

Nature volume 474, pages 427–428 (2011)Cite this article

Subjects

Collapsed trial fuels unfounded vaccine fears.

A clinical trial that came under fire in India threatens to have a dual legacy: inflaming unfounded fears about a lifesaving vaccine and raising new questions about the management of medical research in the country. After four teenage girls taking part in a test of human papillomavirus (HPV) vaccines died last year, the Indian government faced accusations that its citizens were being used as guinea pigs to test dangerous vaccines. A scientific investigation has exonerated the vaccines but uncovered a more familiar problem in India: ethical irregularities.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Authors
  1. Priya Shetty
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related external links

Clinical Trials Registry of India

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shetty, P. Vaccine trial's ethics criticized. Nature 474, 427–428 (2011). https://doi.org/10.1038/474427a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/474427a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing